Andera Partners reported 7 holdings worth US$176M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Oct 16, 2026
Andera Partners reported 7 holdings worth US$176M as of Sep 30, 2026. Largest: Kestra Medical Technologies, Ltd., Mineralys Therapeutics, Inc. and Avalyn Pharma Inc. Filed Oct 16, 2026 (Form 13F).
- Holdings
- 7
- Value as reported
- US$176M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Kestra Medical Technologies, Ltd. | 2.73M | US$77.2M | 43.9% |
| Mineralys Therapeutics, Inc. | 1.59M | US$40M | 22.8% |
| Avalyn Pharma Inc. | 930K | US$26.5M | 15.1% |
| AgomAb Therapeutics NV | 1.54M | US$17.1M | 9.7% |
| Inventiva Sa | 3.63M | US$13.4M | 7.6% |
| Evommune, Inc. | 97,362 | US$804K | 0.46% |
| Abivax Sa | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC